UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Co-delivery of Doxorubicin and Bcl-2 siRNA by Mesoporous Silica Nanoparticles Enhances the Efficacy of Chemotherapy in Multidrug-Resistant Cancer Cells

Small (Weinheim an der Bergstrasse, Germany), 2009-12, Vol.5 (23), p.2673-2677

2009

Volltextzugriff (PDF)

Co-Delivery of Doxorubicin and siRNA with Reduction and pH Dually Sensitive Nanocarrier for Synergistic Cancer Therapy

Small (Weinheim an der Bergstrasse, Germany), 2014-07, Vol.10 (13), p.2678-2687

2014

Volltextzugriff (PDF)

Targeted Co‐delivery of PTX and TR3 siRNA by PTP Peptide Modified Dendrimer for the Treatment of Pancreatic Cancer

Small (Weinheim an der Bergstrasse, Germany), 2017-01, Vol.13 (2), p.np-n/a

2017

Volltextzugriff (PDF)

Microenvironmentally Responsive Chemotherapeutic Prodrugs and CHEK2 Inhibitors Self‐Assembled Micelles: Protecting Fertility and Enhancing Chemotherapy

Advanced materials (Weinheim), 2023-03, Vol.35 (11), p.e2210017-n/a

2023

Volltextzugriff (PDF)

Targeted co‐delivery of paclitaxel and anti P‐gp shRNA by low molecular weight PEI decorated with L‐3,4‐dihydroxyphenylalanine

Biotechnology progress, 2023-03, Vol.39 (2), p.e3310-n/a

2023

Volltextzugriff (PDF)

Injectable and Self-Healing Thermosensitive Magnetic Hydrogel for Asynchronous Control Release of Doxorubicin and Docetaxel to Treat Triple-Negative Breast Cancer

ACS applied materials & interfaces, 2017-10, Vol.9 (39), p.33660-33673

2017

Volltextzugriff (PDF)

Co‐Delivery of Paclitaxel and Interleukin‐12 Regulating Tumor Microenvironment for Cancer Immunochemotherapy

Advanced healthcare materials, 2020-05, Vol.9 (10), p.e1901858-n/a

2020

Volltextzugriff (PDF)

Co-delivery of siRNAs and anti-cancer drugs using layered double hydroxide nanoparticles

Biomaterials, 2014-03, Vol.35 (10), p.3331-3339

2014

Volltextzugriff (PDF)

Light-Activated ROS-Responsive Nanoplatform Codelivering Apatinib and Doxorubicin for Enhanced Chemo-Photodynamic Therapy of Multidrug-Resistant Tumors

ACS applied materials & interfaces, 2018-05, Vol.10 (21), p.17672-17684

2018

Volltextzugriff (PDF)

Synergistically Improved Anti-tumor Efficacy by Co-delivery Doxorubicin and Curcumin Polymeric Micelles

Macromolecular bioscience, 2015-09, Vol.15 (9), p.1252-1261

2015

Volltextzugriff (PDF)

Hyaluronic acid-chitosan nanoparticles for co-delivery of MiR-34a and doxorubicin in therapy against triple negative breast cancer

Biomaterials, 2014-05, Vol.35 (14), p.4333-4344

2014

Volltextzugriff (PDF)

RPV‐modified epirubicin and dioscin co‐delivery liposomes suppress non‐small cell lung cancer growth by limiting nutrition supply

Cancer science, 2020-02, Vol.111 (2), p.621-636

2020

Volltextzugriff (PDF)

A simple and powerful co-delivery system based on pH-responsive metal-organic frameworks for enhanced cancer immunotherapy

Biomaterials, 2017-04, Vol.122, p.23-33

2017

Volltextzugriff (PDF)

Functional exosome-mediated co-delivery of doxorubicin and hydrophobically modified microRNA 159 for triple-negative breast cancer therapy

Journal of nanobiotechnology, 2019-09, Vol.17 (1), p.93-93, Article 93

2019

Volltextzugriff (PDF)

Enhanced anti-tumor efficacy by co-delivery of doxorubicin and paclitaxel with amphiphilic methoxy PEG-PLGA copolymer nanoparticles

Biomaterials, 2011-11, Vol.32 (32), p.8281-8290

2011

Volltextzugriff (PDF)

A modular ROS-responsive platform co-delivered by 10-hydroxycamptothecin and dexamethasone for cancer treatment

Journal of controlled release, 2021-12, Vol.340, p.102-113

2021

Volltextzugriff (PDF)

Effective melanoma cancer suppression by iontophoretic co-delivery of STAT3 siRNA and imatinib using gold nanoparticles

International journal of pharmaceutics, 2017-06, Vol.525 (2), p.407-417

2017

Volltextzugriff (PDF)

Co-delivery of paclitaxel and anti-survivin siRNA via redox-sensitive oligopeptide liposomes for the synergistic treatment of breast cancer and metastasis

International journal of pharmaceutics, 2017-08, Vol.529 (1-2), p.102-115

2017

Volltextzugriff (PDF)

pH-sensitive polymeric nanoparticles for co-delivery of doxorubicin and curcumin to treat cancer via enhanced pro-apoptotic and anti-angiogenic activities

Acta biomaterialia, 2017-08, Vol.58, p.349-364

2017

Volltextzugriff (PDF)

Hyaluronic acid-decorated dual responsive nanoparticles of Pluronic F127, PLGA, and chitosan for targeted co-delivery of doxorubicin and irinotecan to eliminate cancer stem-like cells

Biomaterials, 2015-12, Vol.72, p.74-89

2015

Volltextzugriff (PDF)

Co-delivery of doxorubicin and erlotinib through liposomal nanoparticles for glioblastoma tumor regression using an in vitro brain tumor model

Colloids and surfaces, B, Biointerfaces, 2019-01, Vol.173, p.27-35

2019

Volltextzugriff (PDF)

Autophagy-induced intracellular signaling fractional nano-drug system for synergistic anti-tumor therapy

Journal of colloid and interface science, 2023-09, Vol.645, p.986-996

2023

Volltextzugriff (PDF)

The effect of co-delivery of paclitaxel and curcumin by transferrin-targeted PEG-PE-based mixed micelles on resistant ovarian cancer in 3-D spheroids and in vivo tumors

European journal of pharmaceutics and biopharmaceutics, 2014-10, Vol.88 (2), p.539-550

2014

Volltextzugriff (PDF)

Preparation and physicochemical properties of cisplatin and doxorubicin encapsulated by niosome alginate nanocarrier for cancer therapy

International journal of biological macromolecules, 2023-04, Vol.235, p.123686-123686, Article 123686

2023

Volltextzugriff (PDF)

Enhancing the Management of Metastatic Tumors by Robust Co‐Delivery of 5‐Fluorouracil/MicroRNA‐10b Inhibitor Using EGFR‐Targeted Nanovehicles

Advanced healthcare materials, 2023-06, Vol.12 (15), p.e2202989-n/a

2023

Volltextzugriff (PDF)

1 – 25 von 196

Suche als RSS-Feed

Aktive Filter

ThemaCell Line, Tumor

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(180)
Mit Volltextzugriff
(187)

Publikationsform

Artikel
(196)

Sprache

Englisch
(195)
Chinesisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(188)
Humans
(166)
Co-Delivery
(155)
Animals
(131)
Life Sciences & Biomedicine
(119)
Mice
(98)
Pharmacology & Pharmacy
(86)
Technology
(77)
Materials Science
(75)
Female
(73)
Drug Delivery Systems
(72)
Materials Science, Biomaterials
(66)
Nanoparticles
(57)
Mice, Inbred Balb C
(54)
Chemotherapy
(52)
Nanoscience & Nanotechnology
(51)
Science & Technology - Other Topics
(51)
Nanoparticles - Chemistry
(50)
Engineering
(46)

14 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Co-delivery of Doxorubicin and Bcl-2 siRNA by Mesoporous Silica Nanoparticles Enhances the Efficacy of Chemotherapy in Multidrug-Resistant Cancer Cells

Co-Delivery of Doxorubicin and siRNA with Reduction and pH Dually Sensitive Nanocarrier for Synergistic Cancer Therapy

Targeted Co‐delivery of PTX and TR3 siRNA by PTP Peptide Modified Dendrimer for the Treatment of Pancreatic Cancer

Microenvironmentally Responsive Chemotherapeutic Prodrugs and CHEK2 Inhibitors Self‐Assembled Micelles: Protecting Fertility and Enhancing Chemotherapy

Targeted co‐delivery of paclitaxel and anti P‐gp shRNA by low molecular weight PEI decorated with L‐3,4‐dihydroxyphenylalanine

Injectable and Self-Healing Thermosensitive Magnetic Hydrogel for Asynchronous Control Release of Doxorubicin and Docetaxel to Treat Triple-Negative Breast Cancer

Co‐Delivery of Paclitaxel and Interleukin‐12 Regulating Tumor Microenvironment for Cancer Immunochemotherapy

Co-delivery of siRNAs and anti-cancer drugs using layered double hydroxide nanoparticles

Light-Activated ROS-Responsive Nanoplatform Codelivering Apatinib and Doxorubicin for Enhanced Chemo-Photodynamic Therapy of Multidrug-Resistant Tumors

Synergistically Improved Anti-tumor Efficacy by Co-delivery Doxorubicin and Curcumin Polymeric Micelles

Hyaluronic acid-chitosan nanoparticles for co-delivery of MiR-34a and doxorubicin in therapy against triple negative breast cancer

RPV‐modified epirubicin and dioscin co‐delivery liposomes suppress non‐small cell lung cancer growth by limiting nutrition supply

A simple and powerful co-delivery system based on pH-responsive metal-organic frameworks for enhanced cancer immunotherapy

Functional exosome-mediated co-delivery of doxorubicin and hydrophobically modified microRNA 159 for triple-negative breast cancer therapy

Enhanced anti-tumor efficacy by co-delivery of doxorubicin and paclitaxel with amphiphilic methoxy PEG-PLGA copolymer nanoparticles

A modular ROS-responsive platform co-delivered by 10-hydroxycamptothecin and dexamethasone for cancer treatment

Effective melanoma cancer suppression by iontophoretic co-delivery of STAT3 siRNA and imatinib using gold nanoparticles

Co-delivery of paclitaxel and anti-survivin siRNA via redox-sensitive oligopeptide liposomes for the synergistic treatment of breast cancer and metastasis

pH-sensitive polymeric nanoparticles for co-delivery of doxorubicin and curcumin to treat cancer via enhanced pro-apoptotic and anti-angiogenic activities

Hyaluronic acid-decorated dual responsive nanoparticles of Pluronic F127, PLGA, and chitosan for targeted co-delivery of doxorubicin and irinotecan to eliminate cancer stem-like cells

Co-delivery of doxorubicin and erlotinib through liposomal nanoparticles for glioblastoma tumor regression using an in vitro brain tumor model

Autophagy-induced intracellular signaling fractional nano-drug system for synergistic anti-tumor therapy

The effect of co-delivery of paclitaxel and curcumin by transferrin-targeted PEG-PE-based mixed micelles on resistant ovarian cancer in 3-D spheroids and in vivo tumors

Preparation and physicochemical properties of cisplatin and doxorubicin encapsulated by niosome alginate nanocarrier for cancer therapy

Enhancing the Management of Metastatic Tumors by Robust Co‐Delivery of 5‐Fluorouracil/MicroRNA‐10b Inhibitor Using EGFR‐Targeted Nanovehicles

Aktive Filter

Suchergebnisse filtern